Dinh Chuong Nguyen, Kefan Song, Simbarashe Jokonya, Omeed Yazdani, Drew L Sellers, Yonghui Wang, Abm Zakaria, Suzie H Pun, Patrick S Stayton
The Stimulator of Interferon Genes (STING) pathway is a promising target for cancer immunotherapy. Despite recent advances, therapies targeting the STING pathway are often limited by routes of administration, suboptimal STING activation, or off-target toxicity. Here, we report a dendritic cell (DC)-targeted polymeric prodrug platform (polySTING) that is designed to optimize intracellular delivery of a diamidobenzimidazole (diABZI) small-molecule STING agonist while minimizing off-target toxicity after parenteral administration...
March 27, 2024: ACS Central Science